Beacon retweeted
And here it is hansonwade.com/product/adc/ - Find out what 51 preclinical ADC developers said about what they outsource, when and to whom. Thanks to @World_ADC and @BeaconIntel for their support with producing this.
Beacon retweeted
Our latest report on Allogeneic Cell Therapy Manufacturing is now available to download for free allogeneic-cell-therapies.co… Thanks to @Beaconintel for the clinical data
Beacon retweeted
A new day for antibody drug conjugates:
"The US Food and Drug Administration approved three ADCs in 2019. By the end of last year, 12 in all had been approved, and 145 ADC candidates were active in the clinic..."
go.acs.org/1cs
Story: @cenmag
Image: @BeaconIntel
Beacon retweeted
Hot off the @HansonWade press. My team have just finished a GTx content report with @BeaconIntel on AAV durability. Drop me a DM with your email if you want a copy before general release #AAV #Genetherapy
Beacon retweeted
Today's overview by @HansonWade at #TPDeu once again underscores the speed of innovation in the targeted protein degradation space. Almost impossible to follow everything what is going on. Exciting times! #PROTACs #TPD @Undruggable
Beacon retweeted
Excited to share our research piece on Targeted Protein Degradation (TPD) partnerships. Produced in collaboration with @Undruggable and @BeaconIntel Download a copy for free here: tpd-europe.com/tpd-report/
Beacon retweeted
$PAB | #Patrys CEO and MD, Dr James Campbell, was recently interviewed by the drug development experts @BeaconIntel about our considered path to the clinic. Read the Q&A here 👉 bit.ly/PAB_QA #ASX #research #innovation #cancerresearch #DDR
Beacon retweeted
impossible to overstate the value of the @BeaconIntel #ASH21 abstract primers - #immunotherapy #bispecifics, #cytokines, #celltherapy, ADCs et al.
(and their SITC set, ESMO set, ASCO set and so on).
Beacon retweeted
UPCOMING WEBINAR: Join Ranok's CSO, Dr. Kevin Foley, and discuss the future of targeted protein degradation, and also learn about recently released BEACON database of TPD drugs in development beacon-intelligence.com/tpd-…
Join us, and our panel of experts, as we discuss the development in the targeted protein degradation in a presentation by Beacon Targeted Therapies.
Register for free here: ter.li/rlz4od
Beacon retweeted
Analyzing trends in the CAR-TCR landscape w/ Dr. Vasiliki Zochiou of @BeaconIntel: ow.ly/14CN50EhNen
@VJRegenMed @CAR_TCell #CARTEU #CART #HemOnc #ImmunoOnc #COVID19 #RegenerativeMedicine #tcellrx
Beacon retweeted
Excited for the #WorldADC Europe Virtual Poster Session at 3pm after a morning full of insightful talks by @AstraZeneca, @BeaconIntel, @adctherapeutics, @CatalentPharma & many more pioneers of antibody drug-conjugates!
Beacon retweeted
Replying to @_GeneTherapy
Alexandra says, "It was a pleasure to presenting. Thank you for the opportunity to present this insight. If anyone does have any more questions, I'm happy to answer them."
Beacon retweeted
A talk by our partner @BeaconIntel is happening right now! Alexandra Watt is discussing a Landscape Review of Gene Therapies for Rare Disorders
Check out some insights from the talk below!
#GTxRD2021 #GeneTherapy
Beacon retweeted
Representatives from our partner @BeaconIntel will be attending CAR-TCR Summit EU next week... Will you?
Find out more about the agenda, speakers, and networking opportunities here: buff.ly/3655BfS
#CARTCR #CARTEU #Oncology #cancer #biotech #medicine #immunotherapy
Beacon retweeted
A rapid review of gene therapy’s rise and a quick glimpse into the future with Alexandra Brinkman @BeaconIntel
bit.ly/3nlk5QJ
Beacon retweeted
Thanks to our partners who made CAR-TCR Digital Week a reality! @terumobct @Cytiva @Deloitte @avectas @cellgenix @Covance @LonzaGroup @BeaconIntel #accellix @BeTheMatch @biomerieux @GenScript @WellSkyHealth @miltenyibiotec @Pathoquest @phcbi
@QIAGENscience @SyneosHealth #cartcr
Beacon retweeted
Our partners @BeaconIntel will be participating in 2 session at CAR-TCR Digital Week!
- 1:45 Day 3 - 'Growth in the CAR-TCR Landscape'
- 3:05 Day 3 - Live Q&A with expert speakers
For more info, and the full agenda, click here: buff.ly/3ewnBCM
#CellTherapy #Oncology
Beacon retweeted
I recently wrote a piece for The Medicine Maker discussing a few of the emerging trends in the cell therapy space. Take a look to find out more about advancing allogeneic therapies, targeting solid tumors, and optimising combinations.
themedicinemaker.com/manufac…
Beacon retweeted
The Road Ahead for CAR Therapies from @BeaconIntel with special guest coverage of autologous approaches from @ChrisHeery of @PrecisionBioSci
Listen in for thoughtful commentary on pharmacologic and safety considerations of next gen cell therapies.
youtu.be/lJZ-aRCc7xk
Beacon retweeted
Nice webinar from @BeaconIntel @PrecisionBioSci !! I agree Allo is the CART roadway forward !!

































